In Part 5 of Mission RENAL, a series on Chronic Kidney Disease (CKD) in pets, Dr. JD Foster, small animal internal medicine and nephrology expert joins to discuss non-regenerative anemia in cats with chronic kidney disease and introduce Varenzin™-CA1 (molidustat oral suspension), the first FDA conditionally approved oral treatment for this condition. They explain why non-regenerative anemia matters, how it affects quality of life, and how this innovative medication works differently from older therapies. Sponsored by Elanco, this guide empowers pet owners with Real Education for Navigating Advanced Longevity in dogs and cats with chronic kidney disease. Key Takeaways: Non-regenerative anemia is a common and expected complication of advanced CKD in cats Treating non-regenerative anemia can improve energy, appetite, and overall quality of life Varenzin™-CA1 works by restoring the cat's own erythropoietin production Earlier treatment of non-regenerative anemia may help reduce disease progression stress Oral administration improves compliance and reduces owner-cat stress Please note: Varenzin-CA 1 (molidustat oral suspension) is indicated for the control of non-regenerative anemia associated with chronic kidney disease (CKD) in cats. Discussions within this podcast pertaining to treating anemia with Varenzin-CA1 are solely pertaining to the treatment of CKD-related non-regenerative anemia. Resources & Links: Episode page with pictures and video: Mission RENAL Part 5: Varenzin-CA1 for Non-Regenerative Anemia in Cats with Chronic Kidney Disease Find a veterinary internal medicine specialist near you: Specialist Search Here Our vision is for Your Vet Wants You to Know to be a resource for veterinarians to improve client communication by introducing a discussion about a common topic during the vet visit, then directing the client to a reliable source of engaging, understandable, and accessible information. By doing so, we strive for: 1) increased pet health literacy among pet owners, 2) improved partnership between clients and the veterinary team, 3) improved medical outcomes for pets, and 4) improved quality of life and efficiency for veterinarians. Help support our mission through BUY ME A COFFEE: https://buymeacoffee.com/yourvet Connect with Your Vet! Instagram: https://www.instagram.com/yourvetwantsyoutoknow Facebook: https://www.facebook.com/yourvetwantsyoutoknow Facebook group: https://www.facebook.com/groups/yourvetwantsyoutoknow Mission RENAL is sponsored by Royal Canin and Elanco™ makers of VarenzinTM-CA1 (molidustat oral suspension). Varenzin™-CA1 is indicated for the control of nonregenerative anemia associated with chronic kidney disease (CKD) in cats. Important Safety Information Varenzin™-CA1 is for oral use in cats only and prescribed only by licensed veterinarians. Keep this drug and used syringes out of reach of children. Wash hands immediately after use. In case of accidentally swallowing, call a doctor immediately. Women who are or may become pregnant should use the product with caution. Do not give to pregnant, nursing or breeding cats. Before using Varenzin™-CA1, talk to your veterinarian if your cat is allergic to molidustat, has a history of seizures or thromboembolic disease predisposition. Use with caution in cats younger than 1 year of age. Common side effects include vomiting and high blood pressure. Red blood cell proportion should be monitored. Click here for complete safety information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related